TargetMol

Azadiradione

Product Code:
 
TAR-TN6729
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-TN6729-1mg1mg£177.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN6729-5mg5mg£313.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN6729-1mL1 mL * 10 mM (in DMSO)£369.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN6729-10mg10mg£507.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN6729-25mg25mg£727.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN6729-50mg50mg£978.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN6729-100mg100mg£1,299.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Azadiradione (AZD) from the methanolic extract of seeds of Azadirachta indica
CAS:
26241-51-0
Formula:
C28H34O5
Molecular Weight:
450.575
Purity:
0.9991
SMILES:
[H][C@]12CC[C@@]3(C)[C@@H](C(=O)C=C3[C@]1(C)[C@@H](C[C@@]1([H])C(C)(C)C(=O)C=C[C@]21C)OC(C)=O)c1ccoc1

References

Singh, Kumar B , Vatsa, et al. Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington's Disease[J]. Molecular Neurobiology, 2018. Nelson V K , Ali A , Dutta N , et al. Azadiradione ameliorates polyglutamine expansion disease in Drosophila by potentiating DNA binding activity of heat shock factor 1[J]. Oncotarget, 2016, 7(48):78281-78296.